A Multicenter, Double-Blind, Placebo and Active-Controlled, Dose-Finding Study of MK0974 in the Treatment of Acute Migraine
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2014
At a glance
- Drugs Telcagepant (Primary) ; Rizatriptan
- Indications Migraine; Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 03 Aug 2008 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
- 03 Aug 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 03 Aug 2008 Official title added as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History